Unrelated donor BMT for CML.

被引：0
|
作者：
Dini, G
Lamparelli, T
Rondelli, R
Barbanti, M
Garbarino, L
Lanino, E
Guidi, S
Rosti, G
Alessandrino, EP
Locatelli, F
Marenco, P
Soligo, D
Di Bartolomeo, P
Aversa, F
La Nasa, G
Busca, A
Majolino, I
De Laurenzi, A
Bacigalupo, A
机构：
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
112
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [21] SHWACHMAN-DIAMOND SYNDROME AND MATCHED UNRELATED DONOR BMT
    SMITH, OP
    CHAN, MY
    EVANS, J
    VEYS, P
    BONE MARROW TRANSPLANTATION, 1995, 16 (05) : 717 - 718
  • [22] Unrelated BMT in thalassemia: use of single donor for monozygotic twins
    Erer, B
    Donati, M
    Giardini, C
    Buffi, O
    Iliescu, A
    Stramigioli, S
    Nesci, S
    Polchi, P
    Lucarelli, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S227 - S228
  • [23] Improved outcome for unrelated donor (UD) BMT in children now compares with matched family donor (MFD) BMT.
    Veys, PA
    Meral, A
    Goulden, A
    Hassan, A
    Armstrong, J
    Bennett-Rees, N
    Webb, D
    Gerritsen, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 66 - 66
  • [24] Prognostic factors for allotransplantation in CML.
    Copelan, EC
    Elder, P
    BLOOD, 2005, 106 (11) : 301B - 301B
  • [25] Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia
    H Yagasaki
    Y Takahashi
    A Hama
    K Kudo
    N Nishio
    H Muramatsu
    M Tanaka
    N Yoshida
    K Matsumoto
    N Watanabe
    K Kato
    K Horibe
    S Kojima
    Bone Marrow Transplantation, 2010, 45 : 1508 - 1513
  • [26] Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia
    Yagasaki, H.
    Takahashi, Y.
    Hama, A.
    Kudo, K.
    Nishio, N.
    Muramatsu, H.
    Tanaka, M.
    Yoshida, N.
    Matsumoto, K.
    Watanabe, N.
    Kato, K.
    Horibe, K.
    Kojima, S.
    BONE MARROW TRANSPLANTATION, 2010, 45 (10) : 1508 - 1513
  • [27] Dose matters: Improved disease control with increased cytoreduction in nonablative BMT for late chronic or accelerated phase CML.
    Champlin, RE
    Khouri, I
    Saliba, R
    Cohen, A
    de Lima, M
    Giralt, S
    BLOOD, 2001, 98 (11) : 478A - 478A
  • [28] Delayed and divergent effects of anti-HY minor histocompatibility antigen reactivity after allogeneic BMT for CML.
    Gratwohl, A
    Hermans, J
    van Biezen, A
    van Houwelingen, H
    Niederwieser, D
    Apperley, J
    BLOOD, 1998, 92 (10) : 320A - 320A
  • [29] Unrelated donor marrow transplantation for chronic myeloid leukemia (CML).
    Anasetti, C
    Gooley, T
    Clift, R
    Petersdorf, E
    Martin, P
    Hansen, J
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 724 - 724
  • [30] Improved outcome for closely matched unrelated donor (UD) BMT now compares with matched family donor (MFD) BMT.
    Veys, P
    Meral, A
    Goulden, N
    Hassan, A
    Armstrong, J
    Bennett-Rees, N
    Webb, D
    Gerritsen, B
    BONE MARROW TRANSPLANTATION, 1998, 21 : S31 - S31
12345